WesleyCVan VoorhisMD
Infectious Disease • Seattle, WAProfessor, Medicine, University of Washington School of Medicine
Dr. Van Voorhis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-543-2447
Education & Training
Weill Cornell MedicineClass of 1984, MD
Certifications & Licensure
WA State Medical License 1986 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 6 citationsA comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and...Carlos Diezma-Díaz, Gema Álvarez-García, Javier Regidor-Cerrillo, Guadalupe Miró, Sergio Villanueva-Saz
Frontiers in Veterinary Science. 2023-01-01 - 45 citationsSARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.John E Bowen, Young-Jun Park, Cameron Stewart, Jack T Brown, William K Sharkey
Science Immunology. 2022-12-23 - 63 citationsAccurate de novo design of membrane-traversing macrocycles.Gaurav Bhardwaj, Jacob O'Connor, Stephen Rettie, Yen-Hua Huang, Theresa A Ramelot
Cell. 2022-09-15
Grant Support
- Integrated Research Training on Vector Borne Diseases in Pakistan: Vector Biology, Virology and Disease Epidemiology.AGA KHAN UNIVERSITY (PAKISTAN)2024–2028
- Integrated Research Training on Vector Borne Diseases in Pakistan: Vector Biology, Virology and Disease Epidemiology.AGA KHAN UNIVERSITY (PAKISTAN)2024–2028
- Bumped-Kinase Inhibitor Drug Development for ToxoplasmosisUNIVERSITY OF WASHINGTON2021–2026
- Optimization of Lead BKIs for Cryptosporidiosis TherapyUNIVERSITY OF WASHINGTON2021–2025
- Optimization of Lead BKIs for Cryptosporidiosis TherapyUNIVERSITY OF WASHINGTON2021–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
- University of Washington Arboviral Research Network (UWARN)UNIVERSITY OF WASHINGTON2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
